- Home
- GTE vs VTYX Comparison
GTE vs VTYX Comparison
Compare GTE & VTYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTE
- VTYX
- Stock Information
- Founded
- GTE 2003
- VTYX 2018
- Country
- GTE Canada
- VTYX United States
- Employees
- GTE N/A
- VTYX N/A
- Industry
- GTE Oil & Gas Production
- VTYX Medicinal Chemicals and Botanical Products
- Sector
- GTE Energy
- VTYX Health Care
- Exchange
- GTE Nasdaq
- VTYX Nasdaq
- Market Cap
- GTE 164.0M
- VTYX 154.9M
- IPO Year
- GTE N/A
- VTYX 2021
- Fundamental
- Price
- GTE $4.40
- VTYX $1.17
- Analyst Decision
- GTE
- VTYX Buy
- Analyst Count
- GTE 0
- VTYX 4
- Target Price
- GTE N/A
- VTYX $11.33
- AVG Volume (30 Days)
- GTE 202.1K
- VTYX 965.2K
- Earning Date
- GTE 05-01-2025
- VTYX 05-16-2025
- Dividend Yield
- GTE N/A
- VTYX N/A
- EPS Growth
- GTE N/A
- VTYX N/A
- EPS
- GTE N/A
- VTYX N/A
- Revenue
- GTE $634,805,000.00
- VTYX N/A
- Revenue This Year
- GTE $10.77
- VTYX N/A
- Revenue Next Year
- GTE N/A
- VTYX N/A
- P/E Ratio
- GTE N/A
- VTYX N/A
- Revenue Growth
- GTE N/A
- VTYX N/A
- 52 Week Low
- GTE $3.34
- VTYX $0.78
- 52 Week High
- GTE $10.40
- VTYX $5.66
- Technical
- Relative Strength Index (RSI)
- GTE 48.95
- VTYX 46.01
- Support Level
- GTE $3.99
- VTYX $1.05
- Resistance Level
- GTE $4.56
- VTYX $1.48
- Average True Range (ATR)
- GTE 0.21
- VTYX 0.11
- MACD
- GTE -0.00
- VTYX 0.01
- Stochastic Oscillator
- GTE 50.75
- VTYX 27.91
About GTE Gran Tierra Energy Inc.
Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. A majority of its revenue is derived from its operations in Colombia.
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.